Spiritual Well-Being and Phenoconversion in Huntington’s Disease: Analysis from the Prospective Huntington at Risk Observational Study

<b><i>Objective:</i></b> Spiritual well-being (SWB) has been shown to delay the onset of cognitive decline among older adults predisposed to Alzheimer's disease and related neurodegenerative dementias. It was, however, unknown if SWB is also associated with delay in disease manifestation ("phenoconversion") in rare, genetic neurodegenerative dementias, such as Huntington's disease (HD). Thus, we sought to evaluate the association between SWB and phenocovnersion in people at-risk for HD. <b><i>Methods:</i></b> The "Prospective Huntington At Risk Observation Study" (PHAROS), a large-scale national prospective research study, recruited a substantial cohort of 1001 participants. These participants, who were first-degree relatives of individuals diagnosed with HD and had a 50% chance of carrying the HD genetic mutation, were blinded to their genetic status and underwent repeated clinical assessments every 12 months. The study used Cox proportional models to examine the relationship between SWB and time to phenoconversion while also considering subcomponents of SWB and adjusting for age, sex, and CAG repeat length. <b><i>Results:</i></b> The study found no significant association between SWB and time to phenoconversion in individuals with the HD gene mutation. <b><i>Conclusion:</i></b> While existing data suggest that SWB may be an actionable target to improve health-related quality of life in HD and other serious illnesses, there is a lack of evidence supporting the role of SWB in attenuating phenoconversion in people with the HD genetic mutation. Unlike Alzheimer's, HD may be less responsive to analogous factors in delaying disease onset.

Authors

Institutions

Publication Details

Journal
Journal of Palliative Medicine
Published
2025-03-05
DOI
https://doi.org/10.1089/jpm.2024.0227
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spiritual Well-Being and Phenoconversion in Huntington’s Disease: Analysis from the Prospective Huntington at Risk Observational Study

Leonard L. Sokol, Marissa Ashner, Alexander Kingsbury Smith, Benzi M. Kluger et al.
1 links
Journal of Palliative Medicine
Genetic Neurodegenerative Diseases
article

Spiritual Well-Being and Phenoconversion in Huntington’s Disease: Analysis from the Prospective Huntington at Risk Observational Study

Leonard L. Sokol, Marissa Ashner, Alexander Kingsbury Smith, Benzi M. Kluger, Karen Marder, Danny Bega, Tanya P. Garcia
article en

Abstract

<b><i>Objective:</i></b> Spiritual well-being (SWB) has been shown to delay the onset of cognitive decline among older adults predisposed to Alzheimer's disease and related neurodegenerative dementias. It was, however, unknown if SWB is also associated with delay in disease manifestation ("phenoconversion") in rare, genetic neurodegenerative dementias, such as Huntington's disease (HD). Thus, we sought to evaluate the association between SWB and phenocovnersion in people at-risk for HD. <b><i>Methods:</i></b> The "Prospective Huntington At Risk Observation Study" (PHAROS), a large-scale national prospective research study, recruited a substantial cohort of 1001 participants. These participants, who were first-degree relatives of individuals diagnosed with HD and had a 50% chance of carrying the HD genetic mutation, were blinded to their genetic status and underwent repeated clinical assessments every 12 months. The study used Cox proportional models to examine the relationship between SWB and time to phenoconversion while also considering subcomponents of SWB and adjusting for age, sex, and CAG repeat length. <b><i>Results:</i></b> The study found no significant association between SWB and time to phenoconversion in individuals with the HD gene mutation. <b><i>Conclusion:</i></b> While existing data suggest that SWB may be an actionable target to improve health-related quality of life in HD and other serious illnesses, there is a lack of evidence supporting the role of SWB in attenuating phenoconversion in people with the HD genetic mutation. Unlike Alzheimer's, HD may be less responsive to analogous factors in delaying disease onset.

Journal of Palliative MedicineVol. 28(6)
Northwestern University (US), University of North Carolina at Chapel Hill (US), University of California, San Francisco (US), Columbia University Irving Medical Center (US), University of Rochester Medical Center (US)
Openalex Percentile: Top 95%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.